Sarah Serb
Acute Care · Akron, OHNPI 1780162370
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,328 of the $7,053 with a category attached, or 89.7%. 35 manufacturers reported payments, led by Pulmonx Corporation at 34.1% of the total. Reporting peaked in 2023 at $2,409 and has fallen 69.0% since, to $746 in 2025. Among acute care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$2K
- GSK$951
- AstraZeneca$716
- United Therapeutics Corporation$347
- Actelion Pharmaceuticals US, Inc.$330
- Boehringer Ingelheim$307
- plus $2K from 29 others
What the payments were for
- Travel & lodging$72610%
- Food & beverage$6,32890%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 26 | $2,406 |
| GSK | 77 | $951 |
| AstraZeneca | 39 | $716 |
| United Therapeutics Corporation | 22 | $347 |
| Actelion Pharmaceuticals US, Inc. | 17 | $330 |
| Boehringer Ingelheim | 19 | $307 |
| Jazz Pharmaceuticals Inc. | 15 | $278 |
| Regeneron Healthcare Solutions, Inc. | 11 | $243 |
| Amgen | 7 | $138 |
| Sanofi | 8 | $138 |
| Mylan Specialty L.p. | 7 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Merck | 5 | $97 |
| Insmed, Inc. | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Baxter Healthcare | 4 | $84 |
| Electromed, Inc. | 5 | $78 |
| Bayer | 4 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| Harmony Biosciences LLC | 2 | $37 |
| Philips North America LLC | 2 | $36 |
| Advanced Respiratory, Inc | 2 | $35 |
| Pfizer | 2 | $32 |
| Grifols USA, LLC | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| AbbVie | 1 | $22 |
| Novartis | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CHARTIS CATHETER$1,780
- ZEPHYR DELIVERY CATHETER$1,780
- ZEPHYR ENDOBRONCHIAL VALVE$1,780
- PULMONX CHARTIS TABLET CONSOLE$1,780
How this compares
$7,053 in reported general payments places this provider in the 95th percentile of 1,101 acute care providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UptraviSelexipag | 25 | $565,311 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 154 | $185,837 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 121 | $128,935 |
| Ambrisentan | 28 | $69,148 |
| Spiriva RespimatTiotropium Bromide | 45 | $40,068 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 37 | $27,490 |
| EliquisApixaban | 22 | $20,999 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $19,666 |
| Spiriva HandihalerTiotropium Bromide | 13 | $16,673 |
| DuleraMometasone/Formoterol | 21 | $15,414 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $15,373 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 16 | $15,193 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 229 | $11,226 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $8,739 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $3,596 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Uptravi | $330 | $565,31125 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $951 | $232,994222 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $716 | $152,866161 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $307 | $55,44162 claims |
| PfizerEliquis | $32 | $20,99922 claims |
| MerckDulera | $97 | $15,41421 claims |
| Teva Pharmaceuticals USA, Inc.Proair Respiclick | $94 | $73611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,101 acute care providers in Ohio.
Other acute care in Akron
- Jennifer AnthonyAkron$9K
- Angel SaboAkron$6K
- Megan BerarducciAkron$4K
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.